CareRx Corporation (TSX:CRRX)
3.220
+0.090 (2.88%)
Nov 13, 2026, 4:00 PM EST
CareRx Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, CareRx stock has a consensus rating of "Strong Buy" and an average price target of $4.93. The average 1-year stock price forecast is 53.07% higher than the current stock price, while the lowest is $4.00 (+24.22%) and the highest is $6.25 (+94.10%).
Price Target: $4.93 (+53.07%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CareRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $4.25 | Buy | Maintains | $4.25 | +31.99% | Nov 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $4.50 → $4.00 | Buy | Maintains | $4.50 → $4.00 | +24.22% | Nov 6, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $5.00 | Buy | Maintains | $5.00 | +55.28% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
380.09M
from 370.24M
Increased by 2.66%
Revenue Next Year
402.40M
from 380.09M
Increased by 5.87%
EPS This Year
0.22
from 0.04
Increased by 435.28%
EPS Next Year
0.30
from 0.22
Increased by 36.36%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.